NASDAQ · BLFS
Healthcare · Medical - Instruments & Supplies
$38.61
Up+$0.00 (+0.00%)
Updated Oct 29, 2026, 10:33 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BLFS
1M range · 4 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
BLFS closed at $38.61 after 4 trading sessions, down 0.62% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $37.16 | $38.83 | $36.95 | $38.61 | 4.45M |
| Oct 2, 2026 | $37.02 | $37.98 | $36.83 | $37.30 | 2.85M |
| Oct 1, 2026 | $38.90 | $38.90 | $36.70 | $36.78 | 919.39K |
| Sep 30, 2026 | $39.19 | $39.41 | $38.69 | $38.85 | 1.09M |
The latest Smart Investors Daily articles mentioning BLFS.
Company
Market Activity
Research & News
BLFS research
Company profile and research snapshot.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Benchmark | Hold | — |
| Jul 27, 2026 | Stephens & Co. | Equal-Weight | — |
| Jul 23, 2026 | TD Cowen | Hold | — |
| Jul 23, 2026 | Jefferies | Hold | — |
| Jul 22, 2026 | Lake Street | Hold | — |
No generated briefing is available yet.
Yahoo · Sep 24, 2026
BioLife Solutions (BLFS) is a leader in advanced preservation solutions for cellular matter, with strong technical momentum and a recent 3-year high. Shares are up nearly 60% over the past year. BLFS maintains a 100% “Buy” technical rating and a Trend Seeker “Buy” signal. Analyst sentiment is mixed, with most...
ChartMill · Sep 10, 2026
BLFS blends strong growth, a debt-free balance sheet, and a bullish technical setup, making it a compelling breakout candidate worth watching.
Yahoo · Sep 4, 2026
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index’s 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund’s underweight position […]
ChartMill · Sep 4, 2026
BIOLIFE SOLUTIONS (BLFS) combines high-growth earnings momentum with a consolidating chart, earning top technical and setup ratings for a breakout.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BLFS.
